» Articles » PMID: 28963545

Altered Brain and Gut Responses to Corticotropin-releasing Hormone (CRH) in Patients with Irritable Bowel Syndrome

Overview
Journal Sci Rep
Specialty Science
Date 2017 Oct 1
PMID 28963545
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Stress is a known trigger of irritable bowel syndrome (IBS) and exacerbates its gastrointestinal symptoms. However, underlying the physiological mechanism remains unknown. Here, we investigated hypothalamic-pituitary-adrenal (HPA) axis, colonic motility, and autonomic responses to corticotropin-releasing hormone (CRH) administration as well as brain activity alterations in IBS. The study included 28 IBS patients and 34 age and sex-matched healthy control subjects. IBS patients demonstrated greater adrenocorticotropic hormone (ACTH) responses to CRH than control subjects. Male IBS patients had greater increases in colonic motility than male HCs after CRH. Female IBS patients showed altered sympathovagal balance and lower basal parasympathetic tone relative to female control subjects. Brain responses to rectal distention were measured in the same subjects using functional magnetic resonance imaging, and their associations with individual ACTH responses to CRH were tested. A negative association between ACTH response to CRH and activity in the pregenual anterior cingulate cortex (pACC) during rectal distention was identified in controls but not in IBS patients. Impaired top-down inhibitory input from the pregenual ACC to the HPA axis may lead to altered neuroendocrine and gastrointestinal responses to CRH. Centrally acting treatments may dampen the stress induced physical symptoms in IBS.

Citing Articles

Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage.

Pellegrino R, Gravina A World J Gastroenterol. 2025; 31(8):101357.

PMID: 40062329 PMC: 11886521. DOI: 10.3748/wjg.v31.i8.101357.


Anxiety and Depression in Children with Irritable Bowel Syndrome-A Narrative Review.

Pop D, Man S, Farcau D Diagnostics (Basel). 2025; 15(4).

PMID: 40002584 PMC: 11853794. DOI: 10.3390/diagnostics15040433.


The Latest Data Concerning the Etiology and Pathogenesis of Irritable Bowel Syndrome.

Ionescu V, Gheorghe G, Georgescu T, Bacalbasa N, Gheorghe F, Diaconu C J Clin Med. 2024; 13(17).

PMID: 39274340 PMC: 11395839. DOI: 10.3390/jcm13175124.


Long-Term Implicit Epigenetic Stress Information in the Enteric Nervous System and its Contribution to Developing and Perpetuating IBS.

Noemi C, Bob P, Bokkon I Curr Neuropharmacol. 2024; 22(13):2100-2112.

PMID: 38726788 PMC: 11337685. DOI: 10.2174/1570159X22666240507095700.


Yeast Beta-Glucan Supplementation with Multivitamins Attenuates Cognitive Impairments in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.

Lacasa M, Alegre-Martin J, Sanmartin Sentanes R, Varela-Sende L, Jurek J, Castro-Marrero J Nutrients. 2023; 15(21).

PMID: 37960157 PMC: 10647745. DOI: 10.3390/nu15214504.


References
1.
Fukudo S . IBS: Autonomic dysregulation in IBS. Nat Rev Gastroenterol Hepatol. 2013; 10(10):569-71. DOI: 10.1038/nrgastro.2013.166. View

2.
Elsenbruch S, Lovallo W, Orr W . Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome. Psychosom Med. 2001; 63(5):805-13. DOI: 10.1097/00006842-200109000-00014. View

3.
Fukudo S . Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol. 2007; 42 Suppl 17:48-51. DOI: 10.1007/s00535-006-1942-7. View

4.
Kovacs K . CRH: the link between hormonal-, metabolic- and behavioral responses to stress. J Chem Neuroanat. 2013; 54:25-33. DOI: 10.1016/j.jchemneu.2013.05.003. View

5.
Stengel A, Tache Y . Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med (Maywood). 2010; 235(10):1168-78. PMC: 3169435. DOI: 10.1258/ebm.2010.009347. View